Drug intelligence / Profile preview

Molybdenum trioxide

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems
Administration
Oral, Topical
01

Overview

Molybdenum trioxide (MoO3) is an inorganic compound with widespread industrial applications, including its use as a catalyst, in metallurgy, and in organic electronic devices due to its high work function and favorable energy level alignment. Beyond its industrial utility, it is actively investigated for diverse therapeutic applications. These include its role as a crucial micronutrient in dietary supplements, where it supports essential enzymatic functions and aids detoxification. In nanostructured forms, molybdenum trioxide exhibits antimicrobial activity by generating H+ ions and activating membrane stress in pathogens, and shows promise in cancer therapeutics through mechanisms such like photothermal effects, reactive oxygen species (ROS) production, pyroelectric field generation, and induction of mitochondrial-mediated apoptosis. It also contributes to enhanced wound healing and is explored for advanced photonic and sensing applications.

Other names
MoO3MoO-3MoO 3α-MoO3β-MoO3Molybdic anhydrideMolybditeMolybdic trioxideMolybdenum(VI) oxideMolybdenum oxide
02

Targets

SUOX (Sulfite oxidase)

Beyond the preview

Go deeper on Molybdenum trioxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molybdenum trioxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call